期刊文献+

唐山地区耐药结核分枝杆菌广泛耐药情况的调查 被引量:8

INVESTIGATION ON THE EXTENSIVE DRUG RESISTANT STATUS OF THE DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS IN TANGSHAN AREA
在线阅读 下载PDF
导出
摘要 [目的]分析唐山地区耐药MTB对二线药物的耐药情况,初步探讨本地广泛耐药结核病(XDR-TB)在MDR-TB中的比例。[方法]收集唐山地区2004.11.01~2005.10.31结核病患者痰标本,进行分离培养和表型分群,并对4种二线药物应用绝对浓度法进行耐药性检测。[结果]在所分离的102株耐药结核分枝杆菌中,对二线药物的耐药顺位依次为OFL>PAS>Cp>K,30%MDR-TB菌株同时耐4种二线药物,1/3的MDR-TB属于XDR-TB。[结论]唐山地区MTB二线药物耐药情况严重,MDR-TB中的XDR-TB比例过高。 [Objective]To analyze the state of drug resistance of MTB to the second-line antituberculosis drugs,and preliminary explore the distribution of extensively drug-resistant tuberculosis in MDR-TB in Tangshan area.[Methods]The sputum samples of patients with TB were cdlected from Nov.1th,2004 to Oct.31th,2005 to conduct isolated wlture and phenotypical classification.The four types of second-line antituberculosis drugs were performed to detect the durg-resistance with the method of the absolute concentration.[Results]Out of the 102 isolating MTB,the drug-resistant MTB to the second-line antituberculosis drugs was by the order as follows:OFL 〉 PAS 〉 Cp 〉 K,as well as 30% of the MDR-TB samples resisted four second-line antituberculosis drugs,and one third of MDR-TB belonged to XDR-TB.[Conclusion]Drug resistance to the second-line antituberculosis drugs is very serious in Tangshan area,and the XDR-TB shows high proportion in the MDR-TB.
出处 《现代预防医学》 CAS 北大核心 2007年第24期4728-4729,共2页 Modern Preventive Medicine
关键词 结核分枝杆菌 二线药物 广泛耐药结核病 Mycobacterium tuberculosis Second-line drug Extensively drug-resistant tuberculosis
  • 相关文献

参考文献9

二级参考文献32

  • 1李拥军,王玉华.抗痨并氧氟沙星治疗难治性肺结核32例[J].第四军医大学学报,2003,24(18):1690-1690. 被引量:3
  • 2张敦熔.耐药性的流行病学意义[J].中国防痨杂志,1997,4:155-155.
  • 3全国结核病流行病学抽样调查领导小组.1979全国结核病流行病学抽样调查综合简报[J].中国防痨通讯,1982,2:3-6.
  • 4中华人民共和国卫生部.1984/1985全国结核病流行病学抽样调查资料汇编[M].,-.18-19.
  • 5Dye C, Williams BG, Espinal AM., et al. Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis [J]. Science, 2002, 295: 2042- 2046.
  • 6Cullinan T. Drug-resistant tuberculosis: desperate measure? [J] .The Lancet, 2001, 357: 1124.
  • 7Suarez AG, Floyd K, Portcoarrero J, et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosispatients: a national cohort study in Peru [J]. The Lancet,2002; 359: 181- 190.
  • 8Borgdorff MW, Flord K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low-and middel-income countries[R]. Bulletin of the World Health Organization, 2002; 80 (3): 217-287.
  • 9Tiruviluarnala P, Reichmen LB. Tuberculosis [J]. Annual review of public health, 2002, 23 ( 1 ): 403 - 424.
  • 10Farmer P, Kim JY. Community based approaches to the control of multidrugresistant tuberculosis: introducing "DOTS-plus" [J]. BMJ,1998; 317: 617-670.

共引文献2163

同被引文献82

引证文献8

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部